Cargando…
Avatrombopag: A Review in Thrombocytopenia
Avatrombopag (Doptelet(®)) is an orally administered second generation thrombopoietin receptor agonist (TPO-RA) approved for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory or have an unsatisfactory response to other treatments, as well as for the...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610948/ https://www.ncbi.nlm.nih.gov/pubmed/34709601 http://dx.doi.org/10.1007/s40265-021-01613-y |